ArticleBMC women's health2025
Assessing the effect of hypertension on the severity of coronary artery lesions in young female with acute coronary syndrome.
Article in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe fact that hypertension is associated with atherosclerotic cardiovascular disease in the elderly has been confirmed. However, very little is known about its impact on the severity of coronary artery lesions in young people, especially in young women.
objectiveTo evaluate the effect of essential hypertension (EH) on the severity of coronary artery lesions in young women with acute coronary syndrome (ACS), and to provide a reference for clinical prevention and treatment.
methodsFrom January 2003 to January 2022, 5220 young women (aged ≤ 44 years) who underwent coronary angiography (CAG) due to chest pain symptoms were retrospectively analyzed, of whom 2684 were diagnosed with ACS. After patients with diabetes, hypercholesterolemia, and smoking were excluded, 1772 patients were enrolled. According to whether the patient has EH or not, they were divided into EH combined with ACS group (EH-ASC group; n = 824) and non-hypertension ACS group (control group; n = 948). The severity of coronary artery lesions and the follow-up results after percutaneous coronary intervention (PCI) were compared between the groups.
resultsThere was no significant difference in the type of ACS and the number of lesion vessels between the two groups (P > 0.05). The proportion of type B2 (17.11%) and type C (31.55%) lesions in the EH-ACS group was significantly higher than that (11.39% and 20.68%) in the control group (P < 0.05). The number of stents implanted (1.55 ± 0.95) and the length of stents (23.99 ± 6.77 mm) in the EH-ACS group were significantly greater than those (1.36 ± 0.75 and 22.34 ± 6.91 mm) the in control group (P < 0.05). During a follow-up period of 11-138 months, the cumulative rate of major adverse cardiac events (MACE) and target vessel revascularization (TVR) in the EH-ACS group (22.09% and 20.26%) was significantly higher than that (9.28% and 8.65%) in the control group (P < 0.05).
conclusionHypertension exacerbates the severity of coronary artery lesions in young women with ACS. It is suggested that attention should be paid to the prevention and treatment of hypertension in young women, a special population, to reduce the prevalence of ACS, and a focus on improving hypertension awareness and management among young women could be beneficial in reducing the risk and severity of ACS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.